Flextronics acquires Swiss medical molder

Prior to the deal, which is expected to close in October, Flextronics Medical had 18 production sites overall, with operations in the Americas, Europe, and Asia, including four sites in the U.S., three in Israel, and two each in China, Italy, and Mexico. It produces products and components for consumer diagnostics, drug delivery, microelectronics for implantables, disposable devices, lab diagnostics equipment, imaging, and patient mobility.

RIWISA divides its business into three divisions (industry, consumer, medical), offering specialized injection molding technologies, including multicomponent via three-station rotary table, core-back, and transfer molding; as well as coinjection and inmold labeling capabilities. Medical products include disposables for dentistry, ophthalmology, and diagnostics, as well as biodegradable implants, two-component microfluidics, and syringe systems.

Prior to the deal, RIWISA announced that it would exhibit at this year's K fair (Düsseldorf, Germany; Oct. 16-23) in Hall 12A stand 51-8.